Cecilia Krona

817 total citations
21 papers, 486 citations indexed

About

Cecilia Krona is a scholar working on Molecular Biology, Neurology and Cancer Research. According to data from OpenAlex, Cecilia Krona has authored 21 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Neurology and 9 papers in Cancer Research. Recurrent topics in Cecilia Krona's work include Neuroblastoma Research and Treatments (11 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Glioma Diagnosis and Treatment (5 papers). Cecilia Krona is often cited by papers focused on Neuroblastoma Research and Treatments (11 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Glioma Diagnosis and Treatment (5 papers). Cecilia Krona collaborates with scholars based in Sweden, United States and Germany. Cecilia Krona's co-authors include Tommy Martinsson, Katarina Ejeskär, Frida Abel, Helena Carén, Sven Nelander, Rose‐Marie Sjöberg, Per Kogner, Lingli Li, Panayiotis A. Ioannou and Farida Latif and has published in prestigious journals such as Nature Communications, Oncogene and Scientific Reports.

In The Last Decade

Cecilia Krona

20 papers receiving 481 citations

Peers

Cecilia Krona

NEURO

ONCOL

GENET

Huarui Zheng China

Susanne Fransson Sweden

Hayley Spearman United Kingdom

Ana P. Berbegall Spain

Irene Tadeo Spain

M. Mancini Italy

Kathryn B. Grandinetti United States

Kosuke Funato United States

Cecilia Dyberg Sweden

Shahenda El‐Naggar Egypt

Huarui Zheng China

Cecilia Krona

232 ×0.8

104 ×0.7

110 ×0.8

NEURO

125 ×1.3

ONCOL

117 ×1.6

GENET

Citations per year, relative to Cecilia Krona Cecilia Krona (= 1×) peers Huarui Zheng

Countries citing papers authored by Cecilia Krona

Since Specialization

Citations

This map shows the geographic impact of Cecilia Krona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilia Krona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilia Krona more than expected).

Fields of papers citing papers by Cecilia Krona

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecilia Krona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilia Krona. The network helps show where Cecilia Krona may publish in the future.

Co-authorship network of co-authors of Cecilia Krona

This figure shows the co-authorship network connecting the top 25 collaborators of Cecilia Krona. A scholar is included among the top collaborators of Cecilia Krona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecilia Krona. Cecilia Krona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Doroszko, Milena, Thomas O Millner, Ramy Elgendy, et al.. (2025). The invasion phenotypes of glioblastoma depend on plastic and reprogrammable cell states. Nature Communications. 16(1). 6662–6662. 3 indexed citations

Malik, A., et al.. (2025). Mathematical modeling of multicellular tumor spheroids quantifies inter-patient and intra-tumor heterogeneity. npj Systems Biology and Applications. 11(1). 20–20.

Krona, Cecilia, et al.. (2023). Inference of glioblastoma migration and proliferation rates using single time-point images. Communications Biology. 6(1). 402–402. 7 indexed citations

Gerlee, Philip, Philipp M. Altrock, A. Malik, Cecilia Krona, & Sven Nelander. (2022). Autocrine signaling can explain the emergence of Allee effects in cancer cell populations. PLoS Computational Biology. 18(3). e1009844–e1009844. 11 indexed citations

Koltowska, Katarzyna, et al.. (2021). Real-time evaluation of glioblastoma growth in patient-specific zebrafish xenografts. Neuro-Oncology. 24(5). 726–738. 25 indexed citations

Krona, Cecilia, et al.. (2021). p53-Mediated Radiosensitization of 177Lu-DOTATATE in Neuroblastoma Tumor Spheroids. Biomolecules. 11(11). 1695–1695. 8 indexed citations

Elgendy, Ramy, Thale Kristin Olsen, Cecilia Dyberg, et al.. (2020). Integrative discovery of treatments for high-risk neuroblastoma. Nature Communications. 11(1). 71–71. 44 indexed citations

Masoumi, Katarzyna Chmielarska, Cecilia Krona, Xiaoli Huang, et al.. (2019). Integrin α10, a Novel Therapeutic Target in Glioblastoma, Regulates Cell Migration, Proliferation, and Survival. Cancers. 11(4). 587–587. 29 indexed citations

Sandén, Emma, Cecilia Dyberg, Cecilia Krona, et al.. (2017). Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluation. Scientific Reports. 7(1). 46366–46366. 15 indexed citations

10.

Schmidt, Linnéa, Sathishkumar Baskaran, Patrik Johansson, et al.. (2016). Case-specific potentiation of glioblastoma drugs by pterostilbene. Oncotarget. 7(45). 73200–73215. 15 indexed citations

11.

Sandén, Emma, Cecilia Dyberg, Cecilia Krona, et al.. (2015). Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomas. Journal of Neuro-Oncology. 123(1). 1–13. 12 indexed citations

12.

Krona, Cecilia, Baldur Sveinbjørnsson, Erik Kristiansson, et al.. (2013). ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumours. Molecular Cancer. 12(1). 70–70. 15 indexed citations

13.

Krona, Cecilia, Helena Carén, Rose‐Marie Sjöberg, et al.. (2008). Analysis of neuroblastoma tumour progression; loss of PHOX2B on 4p13 and 17q gain are early events in neuroblastoma tumourigenesis. International Journal of Oncology. 32(3). 575–83. 14 indexed citations

14.

Ejeskär, Katarina, Cecilia Krona, Helena Carén, et al.. (2005). Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death. BMC Cancer. 5(1). 161–161. 57 indexed citations

15.

Carén, Helena, Katarina Ejeskär, Susanne Fransson, et al.. (2005). A cluster of genes located in 1p36 are down-regulated in neuroblastomas with poor prognosis, but not due to CpG island methylation.. Molecular Cancer. 4(1). 10–10. 27 indexed citations

16.

Krona, Cecilia, et al.. (2004). A novel 1p36.2 located gene, APITD1, with tumour-suppressive properties and a putative p53-binding domain, shows low expression in neuroblastoma tumours. British Journal of Cancer. 91(6). 1119–1130. 14 indexed citations

17.

Astuti, Dewi, Mark R. Morris, Cecilia Krona, et al.. (2004). Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma. British Journal of Cancer. 91(10). 1835–1841. 37 indexed citations

18.

Abel, Frida, Rose‐Marie Sjöberg, Cecilia Krona, Staffan Nilsson, & Tommy Martinsson. (2004). Mutations in the N-terminal domain of DFF45 in a primary germ cell tumor and in neuroblastoma tumors. International Journal of Oncology. 25(5). 1297–302. 19 indexed citations

19.

Krona, Cecilia, Katarina Ejeskär, Frida Abel, et al.. (2003). Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2. Oncogene. 22(15). 2343–2351. 45 indexed citations

20.

Abel, Frida, et al.. (2002). Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours. British Journal of Cancer. 86(4). 596–604. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact